XML 57 R42.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Equity (Tables)
12 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Common Stock Reserved for Issuance
The Company has shares of common stock reserved for issuance as follows (in thousands):
March 31, 2024
Common stock warrants516 
2010 Plan
Options outstanding14,842 
2021 Plan
Awards outstanding
2,519 
Shares available for future grant40,823 
2021 ESPP8,002 
Options outstanding outside the Plans2,638 
Total69,340 
Stock Option Activity
Stock option activities within the Plans as well as outside of the Plans were as follows:
Number of Shares
(in thousands)
Weighted-Average
Exercise Price
Average Remaining Contractual Term
(in years)
Aggregate Intrinsic Value (in thousands)
Balance, March 31, 202322,407 $4.39 6.56$627,187 
Options exercised(4,019)3.19 
Options forfeited or expired(908)5.60 
Balance, March 31, 202417,480 4.60 5.72389,931 
Vested and exercisable as of March 31, 202411,896 3.26 5.21281,377 
Vested and expected to vest as of March 31, 202417,480 4.60 5.72389,931 
Stock Options Valuation Assumptions
The fair value of each option on the date of grant was determined using the Black-Scholes option-pricing model with the assumptions set forth in the following table:
Fiscal Year Ended March 31, 2022
Fair value of common stock
$18.41 - $21.41
Volatility
46.5% - 47.0%
Risk-free interest rate
0.77% - 1.02%
Expected term (in years)
5.00 - 6.09
Expected dividend—%
Restricted Stock Unit Activity
The following table summarizes RSU activity (in thousands, except per share information):
Number of SharesWeighted-
Average
Grant Date Fair Value
Unvested balance, March 31, 20231,951 $40.08 
Granted1,300 29.72 
Vested(701)37.96 
Forfeited(457)41.85 
Unvested balance, March 31, 20242,093 33.79 
Stock-Based Compensation Expense
Total stock-based compensation expense recognized in the consolidated statement of operations was as follows (in thousands):
Fiscal Year Ended March 31,
202420232022
Cost of revenue$9,479 $9,634 $4,979 
Research and development11,978 12,583 7,065 
Sales and marketing16,857 16,939 8,108 
General and administrative9,116 8,678 11,290 
Restructuring
3,646 — — 
Total stock-based compensation expense$51,076 $47,834 $31,442